Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M

BenzingaDec 16 07:38 ET

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

TipRanksDec 16 01:10 ET · Ratings

Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering

Trevi TherapeuticsDec 16 00:00 ET

Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 38% Over Last Week

Simply Wall StDec 13 08:33 ET

A Quick Look at Today's Ratings for Trevi Therapeutics(TRVI.US), With a Forecast Between $6 to $9

Moomoo NewsDec 13 08:00 ET · Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 12 16:05 ET